Former HHS Secretary Kathleen Sebelius shares what the country’s top health official can and can’t do, and what she wants senators to know ahead of RFK’s confirmation hearings.
Federal Policy
Posted inHealth Law
Health Policy on the Ballot
Learn more about where President-elect Donald Trump stands on critical health policy issues.
Posted inInsurance
What the Election Could Mean for Obamacare
One of the nation’s leading experts on the Affordable Care Act breaks down its track record the stakes the historic law faces in the lead-up to the election.
Posted inHealth Law
3 Health Care Decisions Awaiting the Next President
The next U.S. president will have to make consequential choices about the Affordable Care Act, prescription drug prices and abortion.
Posted inCost of Care
Race to the Bottom: Where’s the Cavalry?
Some of the most powerful new medicines pose a host of challenges for drug companies trying to copy and sell similar versions on the cheap. Can those companies find a sustainable path forward, or will patients get left stuck paying exorbitant prices?
Posted inCost of Care
3 Big Threats to the Cheap, Effective Medicines That Underpin U.S. Health Care
The U.S. has relied on cheap, effective generic drugs for 40 years. Now that promise is under threat.
Posted inCost of Care
Race to the Bottom: Hard Bargain
America pays less, on average, than any other major country for our generic drugs. But selling essential medicines at such low prices comes with hidden costs — from quality problems to frequent shortages.
Posted inCost of Care
Race to the Bottom: Boom Times
In this first part of our three-part series “Race to the Bottom,” we trace the origins of America’s generic drug industry — groundbreaking, bipartisan legislation signed by President Ronald Reagan that saved us trillions and also got us into trouble.
Posted inPublic Health
A Report Card for Telehealth: What’s Worked and What Hasn’t
As Congress figures out the future of telehealth, we get a reality check from a top researcher about what this care has and has not delivered.
Posted inCost of Care
Is Private Equity Ruining Health Care? It’s Complicated
While stories of private equity firms running amok in health care are easy to find, new research paints a more nuanced picture.